Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The purpose of this study is to suggest a treatment strategy for stage IV gastric cancer by investigating the behavioral difference between initially and recurrent metastatic disease. Methods: We reviewed the medical records of the patients who underwent chemotherapy alone for metastatic gastric cancer between January 2006 and September 2013. Patients were divided into those who underwent chemotherapy for metastatic disease since initial diagnosis (IM group) and for metastatic recurrence after curative surgery (RM group). Survival and causes of death were compared between the 2 groups, and significant prognostic factors were also investi gated. Results: A total of 170 patients were enrolled in this study. Of these patients, 104 were included in the IM group and 66 in the RM group. Overall survival of the IM group did not differ from that of RM (P = 0.569). In the comparison of the causes of death, the IM group had a greater tendency to die from bleeding (P = 0.054) and pneumonia (P = 0.055). In multivariate analysis, bone metastasis (P < 0.001; HR = 2.847), carcinoma peritonei (P = 0.047; HR = 1.766), and the frequency of chemotherapy (P < 0.001; HR = 0.777) were significantly associated with overall survival of IM group. Conclusion: Disease-burden mainly contributes to the prognosis of metastatic gastric cancer, although noncurative gastrec tomy may be helpful in reducing the mortality of initially metastatic disease. Therefore, disease-burden should be also prioritized in determining the treatment strategies for stage IV gastric cancer.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalAnnals of Surgical Treatment and Research
Volume92
Issue number1
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Gastrectomy
Stomach Neoplasms
Drug Therapy
Survival
Cause of Death
Medical Records
Pneumonia
Multivariate Analysis
Hemorrhage
Neoplasm Metastasis
Carcinoma
Bone and Bones
Recurrence
Mortality
Therapeutics

Keywords

  • Gastrectomy
  • Metastasis
  • Prognosis
  • Stomach neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer? / Lee, Chang Min; Choi, In Keun; Kim, Jong Han; Park, Da Won; Kim, Jun Suk; Park, Seong-Heum.

In: Annals of Surgical Treatment and Research, Vol. 92, No. 1, 01.01.2017, p. 23-29.

Research output: Contribution to journalArticle

@article{da218c1c4fda46c08ac33450986382fe,
title = "Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer?",
abstract = "Purpose: The purpose of this study is to suggest a treatment strategy for stage IV gastric cancer by investigating the behavioral difference between initially and recurrent metastatic disease. Methods: We reviewed the medical records of the patients who underwent chemotherapy alone for metastatic gastric cancer between January 2006 and September 2013. Patients were divided into those who underwent chemotherapy for metastatic disease since initial diagnosis (IM group) and for metastatic recurrence after curative surgery (RM group). Survival and causes of death were compared between the 2 groups, and significant prognostic factors were also investi gated. Results: A total of 170 patients were enrolled in this study. Of these patients, 104 were included in the IM group and 66 in the RM group. Overall survival of the IM group did not differ from that of RM (P = 0.569). In the comparison of the causes of death, the IM group had a greater tendency to die from bleeding (P = 0.054) and pneumonia (P = 0.055). In multivariate analysis, bone metastasis (P < 0.001; HR = 2.847), carcinoma peritonei (P = 0.047; HR = 1.766), and the frequency of chemotherapy (P < 0.001; HR = 0.777) were significantly associated with overall survival of IM group. Conclusion: Disease-burden mainly contributes to the prognosis of metastatic gastric cancer, although noncurative gastrec tomy may be helpful in reducing the mortality of initially metastatic disease. Therefore, disease-burden should be also prioritized in determining the treatment strategies for stage IV gastric cancer.",
keywords = "Gastrectomy, Metastasis, Prognosis, Stomach neoplasms",
author = "Lee, {Chang Min} and Choi, {In Keun} and Kim, {Jong Han} and Park, {Da Won} and Kim, {Jun Suk} and Seong-Heum Park",
year = "2017",
month = "1",
day = "1",
doi = "10.4174/astr.2017.92.1.23",
language = "English",
volume = "92",
pages = "23--29",
journal = "Annals of Surgical Treatment and Research",
issn = "2288-6575",
publisher = "Korean Surgical Society",
number = "1",

}

TY - JOUR

T1 - Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer?

AU - Lee, Chang Min

AU - Choi, In Keun

AU - Kim, Jong Han

AU - Park, Da Won

AU - Kim, Jun Suk

AU - Park, Seong-Heum

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Purpose: The purpose of this study is to suggest a treatment strategy for stage IV gastric cancer by investigating the behavioral difference between initially and recurrent metastatic disease. Methods: We reviewed the medical records of the patients who underwent chemotherapy alone for metastatic gastric cancer between January 2006 and September 2013. Patients were divided into those who underwent chemotherapy for metastatic disease since initial diagnosis (IM group) and for metastatic recurrence after curative surgery (RM group). Survival and causes of death were compared between the 2 groups, and significant prognostic factors were also investi gated. Results: A total of 170 patients were enrolled in this study. Of these patients, 104 were included in the IM group and 66 in the RM group. Overall survival of the IM group did not differ from that of RM (P = 0.569). In the comparison of the causes of death, the IM group had a greater tendency to die from bleeding (P = 0.054) and pneumonia (P = 0.055). In multivariate analysis, bone metastasis (P < 0.001; HR = 2.847), carcinoma peritonei (P = 0.047; HR = 1.766), and the frequency of chemotherapy (P < 0.001; HR = 0.777) were significantly associated with overall survival of IM group. Conclusion: Disease-burden mainly contributes to the prognosis of metastatic gastric cancer, although noncurative gastrec tomy may be helpful in reducing the mortality of initially metastatic disease. Therefore, disease-burden should be also prioritized in determining the treatment strategies for stage IV gastric cancer.

AB - Purpose: The purpose of this study is to suggest a treatment strategy for stage IV gastric cancer by investigating the behavioral difference between initially and recurrent metastatic disease. Methods: We reviewed the medical records of the patients who underwent chemotherapy alone for metastatic gastric cancer between January 2006 and September 2013. Patients were divided into those who underwent chemotherapy for metastatic disease since initial diagnosis (IM group) and for metastatic recurrence after curative surgery (RM group). Survival and causes of death were compared between the 2 groups, and significant prognostic factors were also investi gated. Results: A total of 170 patients were enrolled in this study. Of these patients, 104 were included in the IM group and 66 in the RM group. Overall survival of the IM group did not differ from that of RM (P = 0.569). In the comparison of the causes of death, the IM group had a greater tendency to die from bleeding (P = 0.054) and pneumonia (P = 0.055). In multivariate analysis, bone metastasis (P < 0.001; HR = 2.847), carcinoma peritonei (P = 0.047; HR = 1.766), and the frequency of chemotherapy (P < 0.001; HR = 0.777) were significantly associated with overall survival of IM group. Conclusion: Disease-burden mainly contributes to the prognosis of metastatic gastric cancer, although noncurative gastrec tomy may be helpful in reducing the mortality of initially metastatic disease. Therefore, disease-burden should be also prioritized in determining the treatment strategies for stage IV gastric cancer.

KW - Gastrectomy

KW - Metastasis

KW - Prognosis

KW - Stomach neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85009799952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009799952&partnerID=8YFLogxK

U2 - 10.4174/astr.2017.92.1.23

DO - 10.4174/astr.2017.92.1.23

M3 - Article

AN - SCOPUS:85009799952

VL - 92

SP - 23

EP - 29

JO - Annals of Surgical Treatment and Research

JF - Annals of Surgical Treatment and Research

SN - 2288-6575

IS - 1

ER -